Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Compass Therapeutics, Inc. (CMPX)
Company Research
Source: Seeking Alpha
Thomas Schuetz - CEO & Vice Chairman Presentation Unknown Analyst All right. Thank you, everybody, for joining us. I'm here with Thomas from Compass Therapeutics. Thank you so much for joining me this afternoon or this -- I don't know what day is it? Thomas Schuetz CEO & Vice Chairman Thanks so much for inviting us. Happy to be here. Question-and-Answer Session Unknown Analyst Great. Let's start things off with a minute or 2 from you, introducing yourself, the company. What are you looking forward to going into '26? Thomas Schuetz CEO & Vice Chairman Sure. Compass, we're based in Boston. We're a monoclonal antibody discovery and development company in oncology. We currently have 3 drugs in the clinic and a fourth drug about to enter the clinic. So 2026, to answer your question specifically, is going to be an incredibly eventful year for us. We -- for our lead program, Tovecimig, a DLL4xVEGF-A bispecific antibody. We have a readout on the secondary endpoints of
Show less
Read more
Impact Snapshot
Event Time:
CMPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMPX alerts
High impacting Compass Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CMPX
News
- Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $10.00 price target on the stock.MarketBeat
- Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $10.00 price target on the stock.MarketBeat
- Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.MarketBeat
- Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at JMP Securities.MarketBeat
- Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.MarketBeat
CMPX
Earnings
- 8/11/25 - Miss
CMPX
Sec Filings
- 11/18/25 - Form 4
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- CMPX's page on the SEC website